Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
BMJ Case Rep ; 16(11)2023 Nov 17.
Artículo en Inglés | MEDLINE | ID: mdl-37977830

RESUMEN

We report about a man in his mid-50s who was prescribed pregabalin (150 mg/day) for neuropathic pain due to a herniated intervertebral disc. Four weeks later, he presented to the emergency room with symptoms consistent with delirium. After ruling out acute intoxication with a substance and neurological causes, collateral information from the family and review of his medical chart indicated potential discontinuation syndrome owing to pregabalin. Following the successful treatment and resolution of delirium, the patient revealed he had been consistently consuming pregabalin doses upwards of 2 g/day over the past 2 weeks, leading to the premature exhaustion of his prescription and an abrupt cessation. The case findings underscore the necessity for physicians to recognise the potential for pregabalin misuse and the associated withdrawal risks, including delirium.


Asunto(s)
Delirio , Neuralgia , Trastornos Relacionados con Sustancias , Masculino , Humanos , Pregabalina/efectos adversos , Trastornos Relacionados con Sustancias/complicaciones , Síndrome , Neuralgia/etiología , Delirio/inducido químicamente , Delirio/tratamiento farmacológico , Delirio/complicaciones
2.
Cureus ; 15(11): e49025, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-38024021

RESUMEN

We report the case of a male in his twenties who was prescribed 10 mg of zolpidem daily for sleep disturbances. Within one month, he self-augmented the dose to 30 mg daily. Unable to secure an authorized refill, he sought unauthorized suppliers and increased his daily intake to 70 mg over eight months. One day after his medication supply was depleted, he presented to the emergency department with symptoms indicative of acute delirium. Delirium was successfully alleviated within six hours using lorazepam. This was followed by a five-day lorazepam tapering regimen during the patient's hospital stay and then a subsequent four-day taper in an outpatient setting. This case highlights the dangers associated with zolpidem misuse, the swift onset of withdrawal symptoms following abrupt discontinuation, and the crucial importance of rigorous prescription monitoring and patient education regarding the risks of unguided dosage modifications and the sudden cessation of zolpidem.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA